Nachrichten zur Pulse Biosciences Inc. Aktie

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +18.75% and +5.60%, respectively, for the quarter ended December 2025. Do…

Pulse Biosciences shares late-breaking AF data showing up to 100% procedural success, fast procedures and low adverse events for nPulse.…

Pulse Biosciences stock rises after positive cardiac catheter study data…

…

Pulse Biosciences drops 35% after InvestingPro’s "Overvalued" warning…

Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving…

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do…

…

Pulse Biosciences reports wider Q4 loss, shares dip…

Pulse Biosciences director Robert Duggan buys $972,343 in stock…

…

…

Earnings call: Pulse Biosciences reports progress with CellFX system…

…

Earnings call: Pulse Biosciences advances with FDA clearances and trials…

…

…